Gary Glick, Odyssey Therapeutics CEO
After bringing his total raise for Odyssey to $386M, Gary Glick is ready to start inking deals. Just watch
If there’s one thing Gary Glick excels at, it’s raising money for his startups. Even in this soured financial environment.
No sooner had he closed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
